Technical Analysis for HROW - Harrow Health, Inc.
| ADX | Long-Term | Intermediate-Term | Short-Term |
|---|---|---|---|
| Weak or Absent | Down | Up | Up |
| See historical HROW trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Calm After Storm | Range Contraction | 0.00% | |
| Upper Bollinger Band Walk | Strength | 0.00% | |
| Inside Day | Range Contraction | 0.00% | |
| Above Upper BB | Strength | 0.00% | |
| Upper Bollinger Band Touch | Strength | 0.00% | |
| 200 DMA Resistance | Bearish | -0.35% | |
| Slingshot Bearish | Bearish Swing Setup | -0.35% | |
| Crossed Above 20 DMA | Bullish | -0.35% | |
| Crossed Above 50 DMA | Bullish | -0.35% | |
| MACD Bullish Signal Line Cross | Bullish | -0.35% |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 11/13/2019
- Sector: Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
Harrow Health, Inc., formerly Imprimis Pharmaceuticals, Inc., is engaged in the development, production and dispensing of compounded pharmaceuticals. The Company operates through the business of developing drug therapies and providing such therapies through sterile and non-sterile pharmaceutical compounding services segment. The Company owns, markets and dispenses a portfolio of compounded therapeutic in several therapeutic areas, including ophthalmology, urology, otolaryngology and infectious diseases. The Company is also developing Custom Compounding Choice business, which is focused on developing and dispensing a portfolio of non-proprietary compounded drugs for humans and animals in therapeutic areas that may be overlooked by commercial pharmaceutical companies. The Company also offers customizable compounding products that consist of sterile injectable and non-sterile integrative medicine therapies that are used in various therapeutic areas.
Health Pharmaceutical Pharmaceuticals Infectious Diseases Pharmacy Pharmaceutical Industry In China Pharmaceutical Sciences Drug Therapies
Health Pharmaceutical Pharmaceuticals Infectious Diseases Pharmacy Pharmaceutical Industry In China Pharmaceutical Sciences Drug Therapies
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength | |||
| Summary: | Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies. | ||
See more HROW news...
Indicators
| Indicator | Value |
|---|---|
| 52 Week High | 8.99 |
| 52 Week Low | 4.1 |
| Average Volume | 180,978 |
| 200-Day Moving Average | 5.8968 |
| 50-Day Moving Average | 5.3644 |
| 20-Day Moving Average | 5.075 |
| 10-Day Moving Average | 5.057 |
| Average True Range | 0.3238 |
| ADX | 20.72 |
| +DI | 29.551 |
| -DI | 16.3464 |
| Chandelier Exit (Long, 3 ATRs ) | 4.9386 |
| Chandelier Exit (Short, 3 ATRs ) | 5.5414 |
| Upper Bollinger Band | 5.5741 |
| Lower Bollinger Band | 4.5759 |
| Percent B (%b) | 1.09 |
| BandWidth | 19.668966 |
| MACD Line | -0.0275 |
| MACD Signal Line | -0.1053 |
| MACD Histogram | 0.0778 |
| Fundamentals | Value |
|---|---|
| Market Cap | 113.56 Million |
| Num Shares | 20.1 Million |
| EPS | -0.81 |
| Price-to-Earnings (P/E) Ratio | -6.99 |
| Price-to-Sales | 1.39 |
| Price-to-Book | 4.30 |
| PEG Ratio | 0.00 |
| Dividend | 0.00 |
| Dividend Yield | 0.00% |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 6.20 | ||||
| Resistance 3 (R3) | 6.17 | 5.97 | 6.11 | ||
| Resistance 2 (R2) | 5.97 | 5.83 | 5.98 | 6.08 | |
| Resistance 1 (R1) | 5.81 | 5.74 | 5.71 | 5.84 | 6.05 |
| Pivot Point | 5.61 | 5.61 | 5.56 | 5.62 | 5.61 |
| Support 1 (S1) | 5.45 | 5.47 | 5.35 | 5.48 | 5.27 |
| Support 2 (S2) | 5.25 | 5.38 | 5.26 | 5.24 | |
| Support 3 (S3) | 5.09 | 5.25 | 5.21 | ||
| Support 4 (S4) | 5.12 |
